Edgemoor Investment Advisors’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$16.6M Buy
108,581
+251
+0.2% +$38.5K 1.31% 23
2025
Q4
$14.9M Sell
108,330
-710
-0.7% -$93K 1.16% 23
2025
Q3
$14M Sell
109,040
-1,699
-2% -$207K 1.08% 25
2025
Q2
$13.4M Sell
110,739
-1,595
-1% -$180K 1.16% 23
2025
Q1
$12.5M Sell
112,334
-7,349
-6% -$782K 1.15% 23
2024
Q4
$11.6M Sell
119,683
-6,761
-5% -$721K 1.03% 25
2024
Q3
$14.5M Sell
126,444
-3,525
-3% -$400K 1.26% 21
2024
Q2
$13.8M Sell
129,969
-3,908
-3% -$392K 1.29% 20
2024
Q1
$13M Sell
133,877
-1,329
-1% -$136K 1.22% 21
2023
Q4
$13.7M Sell
135,206
-1,833
-1% -$177K 1.43% 19
2023
Q3
$14M Sell
137,039
-1,853
-1% -$188K 1.65% 16
2023
Q2
$14M Sell
138,892
-1,793
-1% -$179K 1.58% 15
2023
Q1
$12.9M Sell
140,685
-461
-0.3% -$40.3K 1.57% 14
2022
Q4
$12.8M Sell
141,146
-355
-0.3% -$29.9K 1.6% 18
2022
Q3
$10.8M Sell
141,501
-1,910
-1% -$158K 1.43% 19
2022
Q2
$12.1M Sell
143,411
-3,806
-3% -$334K 1.53% 18
2022
Q1
$12.9M Sell
147,217
-3,183
-2% -$276K 1.36% 19
2021
Q4
$13.2M Sell
150,400
-2,433
-2% -$202K 1.35% 19
2021
Q3
$12.5M Sell
152,833
-36,800
-19% -$3.31M 1.42% 18
2021
Q2
$17.3M Sell
189,633
-552
-0.3% -$49.2K 1.61% 18
2021
Q1
$16.3M Buy
190,185
+1,070
+0.6% +$96K 1.63% 17
2020
Q4
$17.9M Buy
189,115
+76
+0% +$6.64K 2% 14
2020
Q3
$16.4M Sell
189,039
-2,897
-2% -$251K 2.03% 12
2020
Q2
$16.8M Buy
191,936
+3,802
+2% +$328K 2.25% 12
2020
Q1
$15.5M Sell
188,134
-4,940
-3% -$441K 2.53% 9
2019
Q4
$18.3M Sell
193,074
-6
-0% -$538 2.09% 10
2019
Q3
$16.8M Sell
193,080
-8,354
-4% -$750K 2.07% 12
2019
Q2
$18.4M Sell
201,434
-23,633
-11% -$2M 2.32% 8
2019
Q1
$19.4M Sell
225,067
-368
-0.2% -$29.5K 2.55% 7
2018
Q4
$17.3M Sell
225,435
-1,446
-0.6% -$113K 2.59% 8
2018
Q3
$17.5M Sell
226,881
-693
-0.3% -$51.2K 2.17% 10
2018
Q2
$15.4M Sell
227,574
-2,146
-0.9% -$148K 2.06% 12
2018
Q1
$16.6M Sell
229,720
-172
-0.1% -$13.1K 2.22% 11
2017
Q4
$17.9M Sell
229,892
-2,330
-1% -$176K 2.26% 13
2017
Q3
$17.9M Sell
232,222
-1,968
-0.8% -$149K 2.42% 9
2017
Q2
$17.5M Buy
234,190
+4,081
+2% +$289K 2.39% 9
2017
Q1
$15.3M Sell
230,109
-4,397
-2% -$293K 2.18% 10
2016
Q4
$15.3M Sell
234,506
-4,952
-2% -$321K 2.33% 9
2016
Q3
$16.9M Sell
239,458
-1,485
-0.6% -$108K 2.61% 6
2016
Q2
$17.8M Sell
240,943
-5,123
-2% -$354K 2.81% 7
2016
Q1
$16M Sell
246,066
-6,518
-3% -$443K 2.49% 8
2015
Q4
$19.5M Sell
252,584
-3,130
-1% -$249K 2.92% 6
2015
Q3
$21.1M Sell
255,714
-2,883
-1% -$257K 3.2% 3
2015
Q2
$22.8M Sell
258,597
-4,766
-2% -$437K 3.32% 3
2015
Q1
$23.3M Sell
263,363
-1,925
-0.7% -$171K 3.3% 3
2014
Q4
$22M Sell
265,288
-2,584
-1% -$214K 3.24% 3
2014
Q3
$22.6M Sell
267,872
-3,782
-1% -$306K 3.32% 2
2014
Q2
$22M Sell
271,654
-10,142
-4% -$798K 3.24% 2
2014
Q1
$21.5M Buy
281,796
+1,568
+0.6% +$114K 3.39% 2
2013
Q4
$20.2M Sell
280,228
-1,944
-0.7% -$135K 3.2% 3
2013
Q3
$19.4M Sell
282,172
-2,400
-0.8% -$159K 3.38% 3
2013
Q2
$18M Buy
+284,572
New +$18.5M 3.2% 2

Other funds holding NVS

Edgemoor Investment Advisors's NVS Position: Q1 2026 in Review

Edgemoor Investment Advisors increased its Novartis (NVS) stake by 0.23% in Q1 2026, buying an estimated $38.5K and bringing the position to 108,581 shares worth $16.6M. The position accounts for 1.31% of the portfolio, ranked #23.

Edgemoor Investment Advisors first reported a position in NVS in Q2 2013 and has held it in 52 quarters since. The position peaked at $23.3M in Q1 2015. 1,591 funds tracked by Wall St. Rank hold NVS as of Q1 2026.

  • Edgemoor Investment Advisors held 108,581 shares of Novartis worth $16.6M as of Q1 2026.
  • Edgemoor Investment Advisors bought 251 Novartis shares in Q1 2026, an estimated $38.5K.
  • Novartis made up 1.31% of Edgemoor Investment Advisors's portfolio in Q1 2026, its #23 holding.
  • Edgemoor Investment Advisors first reported a position in Novartis in Q2 2013 and has held it in 52 quarters since.
  • Edgemoor Investment Advisors's Novartis position peaked at $23.3M in Q1 2015.
  • 1,591 funds tracked by Wall St. Rank held Novartis as of Q1 2026.

Based on Edgemoor Investment Advisors's 13F filing for Q1 2026, filed 13 May 2026.